Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
Mutter RW, Golafshar MA, Buras MR, Comstock BP, Jacobson M, DeWees T, Remmes NB, Francis LN, Boughey JC, Ruddy KJ, McGee LA, Afzal A, Vallow LA, Furutani KM, Deufel CL, Shumway DA, Kim H, Liu MC, Degnim AC, Jakub JW, Vern-Gross TZ, Wong WW, Patel SH, Vargas CE, Stish BJ, Waddle MR, Pafundi DH, Halyard MY, Corbin KS, Hieken TJ, Park SS. Mutter RW, et al. Among authors: halyard my. Int J Radiat Oncol Biol Phys. 2024 Sep 17:S0360-3016(24)03389-3. doi: 10.1016/j.ijrobp.2024.09.019. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39299551 Free article.
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Thorpe CS, DeWees TA, Laughlin BS, Vallow LA, Seneviratne D, Pockaj BA, Cronin PA, Halyard MY, Vern-Gross TZ, McGee LA, McLaughlin SA, Voss MM, Golafshar MA, Bulman GF, Vargas CE. Thorpe CS, et al. Among authors: halyard my. Adv Radiat Oncol. 2022 Oct 21;8(1):101111. doi: 10.1016/j.adro.2022.101111. eCollection 2023 Jan-Feb. Adv Radiat Oncol. 2022. PMID: 36483068 Free PMC article.
Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
Laughlin BS, Corbin KS, Toesca DAS, Thorpe CS, Golafshar MA, Pockaj B, Cronin P, McGee LA, Halyard MY, Mutter RW, Keole SR, Park SS, Shumway DA, Vern-Gross TZ, Vallow L, Wong WW, DeWees TA, Vargas CE. Laughlin BS, et al. Among authors: halyard my. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1049-1059. doi: 10.1016/j.ijrobp.2023.10.018. Epub 2023 Oct 31. Int J Radiat Oncol Biol Phys. 2024. PMID: 37914139 Free article. Clinical Trial.
Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.
Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Vora SA, et al. Among authors: halyard my. Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1053-8. doi: 10.1016/j.ijrobp.2007.01.043. Epub 2007 Mar 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17398023
Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry.
Thorpe CS, DeWees TA, Golafshar MA, Bhangoo RS, Vern-Gross TZ, McGee LA, Wong WW, Halyard MY, Keole SR, Vargas CE. Thorpe CS, et al. Among authors: halyard my. J Patient Rep Outcomes. 2022 Jan 10;6(1):3. doi: 10.1186/s41687-021-00408-9. J Patient Rep Outcomes. 2022. PMID: 35006393 Free PMC article.
99 results